Skip to main content
Premium Trial:

Request an Annual Quote

ACD Announces Preferred Partnership with MicroMatrices

NEW YORK (GenomeWeb) – Advanced Cell Diagnostics announced today a preferred partnership agreement with Dundee, UK-based MicroMatrices to develop applications of its RNAscope technology.

ACD's RNAscope assays allow for single RNA molecule detection of formalin-fixed, paraffin-embedded tissue samples, offering quantitative molecular detection with morphological context in a single assay. MicroMatrices has expertise in using RNAscope to detect RNA-based biomarkers in situ, the companies said in a statement, and will now aim to develop preclinical applications of the technology.

"The power and versatility of RNAscope has been an invaluable tool to enable us to solve mode of action/efficacy/toxicity challenges for our clients in the pharmaceutical, agrochemical, and chemical industries," Simon Plummer, managing director of MicroMatrices, said.

Financial and other terms of the deal were not provided.

MicroMatrices is a service provider specializing in high resolution cell type-specific analysis to characterize toxicological responses in different cell types and tissues.

Hayward, Calif.-based ACD develops cell and tissue-based diagnostic tests for personalized medicine.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.